Group 1 - The second "Belt and Road" Science and Technology Exchange Conference was held in Chengdu, China, from June 10 to 12, focusing on building a technology innovation community [1] - Approximately 1,500 participants, including scientists, business leaders, and government officials, attended the conference to discuss development and cooperation [1] - The conference featured 38 activities across five main categories, emphasizing the importance of technology as a bridge connecting the world [1] Group 2 - The conference showcased over 400 technological achievements in various fields, including artificial intelligence, biomedicine, modern agriculture, and equipment manufacturing [2] - Eight significant outcomes were announced during the conference, highlighting the vibrant cooperation in technology innovation along the "Belt and Road" [2] - The International Meridian Circle Scientific Program, initiated by China, has attracted 36 international organizations and research institutions for collaboration [2] Group 3 - Turing Brain Recovery Innovation Technology from Singapore presented its AI brain-machine interface technology, emphasizing the opportunities for technological cooperation opened by the "Belt and Road" initiative [3] - CATL demonstrated its innovations in green transformation, claiming that its investments in battery technology have enabled 18 million vehicles globally to transition to new energy [3] Group 4 - The conference served as a valuable platform for developing countries to learn from each other's innovation experiences and establish a technology innovation community [4] - Malaysia's Minister of Science and Technology highlighted the "Belt and Road" initiative as a global platform for cooperation in AI, green technology, and quantum computing [4] - The "Technology Poverty Alleviation: Goals and Practices" forum was held to share experiences and explore innovative paths for poverty alleviation through technology [4] Group 5 - The establishment of the ANSO International Technology Enterprise Alliance aims to integrate multinational technology enterprises' capabilities and international cooperation networks [5] - Chinese enterprises are transitioning from traditional product trade to providing key intermediates and solutions, enhancing international cooperation efficiency [5] - The conference was seen as a timely opportunity to promote international collaboration in addressing common challenges and unleashing innovation potential [5]

Core Viewpoint - The integration of traditional Chinese medicine (TCM) culture into primary and secondary education in Sichuan Province is being actively promoted, with various schools implementing programs to enhance students' understanding and appreciation of TCM [1][2][3] Group 1: Implementation of TCM Education - The "14th Five-Year Plan" for the promotion of TCM culture aims to incorporate TCM into health education and traditional culture education in schools [1] - TCM courses are among the most popular elective subjects at schools like Longma Tan District Tianli Chunyu School, which has dedicated classrooms for TCM education [1] - Schools such as Chengdu Jinli Primary School integrate TCM into various subjects and regularly invite experts to teach students about acupuncture and preventive health [1] Group 2: Special Events and Activities - Special events, such as the Dragon Boat Festival, are utilized to educate students about TCM, with experts explaining the uses of herbs like mugwort and cyperus [2] - Interactive activities, such as "The TCM Adventure in the Museum," engage students in learning about acupuncture and TCM techniques [2] Group 3: Hands-on Experience and Engagement - Practical activities, such as making sachets and herbal preparations, are conducted to deepen students' understanding of TCM [3] - Schools encourage students to grow medicinal herbs, fostering a hands-on approach to learning about TCM [3] - The provincial TCM bureau reports that thousands of promotional activities related to TCM culture are held annually in schools across the province [3]

Core Insights - The rise of night markets in Nanjing is enhancing the city's nightlife and community engagement, featuring diverse offerings from food to traditional culture and wellness [1][4][6] - The integration of AI technology in traditional Chinese medicine is gaining traction, with smart diagnostic tools being utilized in numerous healthcare settings [2][7] - Community-driven initiatives like "燕子集" are fostering neighborly connections and stimulating local economies through regular events that blend culture, food, and social interaction [3][6] Group 1: Night Markets - Nanjing's night markets are becoming vibrant social hubs, attracting residents with a variety of food and cultural experiences [1][4] - The "星乐市集" in Jiangbei New District is designed as a "living room" for the community, catering to local residents and office workers with dining and entertainment options [5][6] - The popularity of these markets is contributing to the local economy and enhancing the sense of community among residents [6][7] Group 2: Traditional Chinese Medicine and Technology - The introduction of AI diagnostic tools, such as the intelligent pulse and tongue diagnosis devices, is revolutionizing traditional Chinese medicine practices [2][7] - These technologies are increasingly being adopted in hospitals and clinics, reflecting a growing interest in wellness among younger demographics [2][6] Group 3: Community Engagement - Events like "燕子集" are not just activities but serve as platforms for community governance and enhancing nighttime consumption [6][7] - The initiative aims to bring various cultural and culinary experiences directly to residents, fostering a sense of belonging and community spirit [3][6]

Group 1 - The core initiative "Together, Building China's Heart" has been active for 18 years, providing medical assistance to over 1 million people across various regions, particularly focusing on congenital heart disease [1][3][4] - The program has mobilized over 32,000 medical experts from more than 3,000 medical institutions, expanding its services from congenital heart disease to multiple medical specialties [3][4] - The initiative has successfully completed over 3,000 surgeries for children with congenital heart disease and conducted more than 3,000 health education activities [4] Group 2 - The "1+1 Employee Relief Fund" was established in 2009 to support employees in need, with a total donation of 8.526 million yuan and 8.335 million yuan used for relief [6][7] - The fund not only assists employees but also extends support to their families, demonstrating the company's commitment to employee welfare [7] - The fund has positively influenced company culture, fostering a sense of community and responsibility among employees [7] Group 3 - The company emphasizes the integration of social responsibility with business operations, maintaining a strong commitment to innovation and shareholder returns [9][10] - Since its listing in 2016, the company has paid out 9.183 billion yuan in cash dividends and buybacks, exceeding the raised capital [9] - The company has contributed nearly 32 billion yuan in taxes since its establishment, highlighting its role in supporting local economic development [9] Group 4 - The company is actively involved in research and development, focusing on innovative drugs and high-quality generics, while also expanding its international presence [10] - The company's philosophy of "altruism" is seen as complementary to profitability, enhancing its social reputation and employee loyalty [10]

昨天（6月10日），由中国中医科学院西苑医院主办，西苑医院苏州医院、苏州市中医医院承办的 科研联动培训平台"杏苑讲堂"正式启动。该平台将构建中医药产、学、研、用新生态，进一步畅通北 京、苏州中医药领域的创新科研脉络，助推国家中医医学中心、国家区域医疗中心建设。 科技成果转化是中医药走向现代化、国际化的必由之路。市卫健委有关负责人介绍，"十四五"以 来，全市中医药系统累计申报课题2267项，立项855项，其中"国自然"项目47项。通过吴门医派验方评 价与转化重点实验室，三个发明项目通过苏州国际生物医药产业路演，与企业签订战略合作协议。作为 生物医药创新高地，苏州还获批为国家中医药传承创新发展试验区。全市中医药系统将大力培育临床科 研人才，推动成果转化，让更多"藏在古籍中的方子"转化为"惠及百姓的良方"。 中国中医科学院西苑医院苏州医院、苏州市中医医院副院长刘玥介绍，"杏苑讲堂"将立足"名家荟 萃、智慧共享"定位，着力打造中医药学术交流的思想高地，计划每月邀请两位在中医药临床专科、学 科建设或科技成果转化领域的顶尖专家，通过专题授课、案例研讨、跨界对话等形式，传播前沿理念， 激发创新思维。首期讲堂邀请的两位学者分 ...

Core Viewpoint - The collaboration between the National Key Laboratory for New Drug Discovery and Baizhitang Traditional Chinese Medicine Group marks a significant integration of national-level research platforms with leading enterprises in traditional Chinese medicine, injecting new momentum into the modernization of TCM research and innovative drug development [1][2]. Group 1: Research Collaboration - The newly established research institute will focus on chronic disease research, particularly diabetes and nodular diseases, leveraging Baizhitang's core technologies and medical service systems [2][4]. - The collaboration aims to enhance the understanding of traditional Chinese medicine formulations and their mechanisms, transitioning from empirical medicine to evidence-based medicine [4][10]. Group 2: Innovation and Talent Development - The research institute will serve as a new platform for collaborative innovation, facilitating the sharing of research facilities and data resources between the laboratory and Baizhitang [6]. - A dual-subject mechanism for results transformation will be established, with the laboratory focusing on basic research and Baizhitang providing clinical scenarios and industrial resources [6]. - The partnership will also emphasize the cultivation of interdisciplinary talents in areas such as "Traditional Chinese Medicine + Bioinformatics" and "Traditional Chinese Medicine Chemistry + Clinical Medicine" [6]. Group 3: Strategic Importance - This collaboration is a key step in Baizhitang's strategy to integrate production, learning, research, and education, enhancing its competitiveness in the research sector [9]. - The operationalization of the research institute is expected to lead to a new phase of precision, intelligence, and internationalization in TCM research, contributing to high-quality development in the industry [10].

2025年6月10日，全泰堂集团有限公司董事长韩辉军一行莅临药易购（300937）进行商务洽谈，并正式 签署战略合作协议，药易购将携手全泰堂成立"合纵全泰堂"共同探索合作新模式，共同经营中华老字 号，以进一步弘扬中华民族品牌价值，推动大健康与中医药文化发展。药易购董事长李燕飞、总裁陈顺 军等共同出席。 药易购董事长李燕飞首先对全泰堂集团有限公司董事长韩辉军一行的到来表示热烈欢迎，并对全泰堂自 1889年创立以来的深厚积淀给予了高度赞誉。 数智化破圈：互联网基因激活老字号产业新潜能 资源破壁与价值重构：构筑大健康产业护城河 全泰堂集团有限公司董事长韩辉军在会上表示，此次与药易购的合作意义深远，双方的深度融合是战略 落地与产业数智化转型的关键一步。他表示，本次合作以资源破壁、价值重构为核心，聚焦品牌数字 化、渠道智能化和产品创新化，全泰堂深耕大健康产业，协同药易购产业互联网数智化能力，将突破地 域局限，精准对接消费需求，提升品牌影响力；药易购则将进一步充实产品矩阵、拓展业务边界，相信 双方在共同的努力下，一定能加速实现在中医药、药食同源等板块的衍生价值释放，为中医药文化传承 与产业高质量发展树立新标杆。 她提到， ...

校地合作赋能中 医药事业高质量 发展！高州市中 医院成功举办中 层管理干部培训 班_南方+_南方 plus 为进一步提升医 院中层管理干部 的管理能力和团 队凝聚力，增强 医院治理水平， 推动医院高质量 发展，6月7-8 日，高州市中医 院中层管理干部 培训班（第一 期）在时珍楼九 楼学术厅隆重举 行。 6月7日上午，广 东省中医药学会 副会长金世明， 高州市卫生健康 局党组成员、副 局长范小玲，广 州中医药大学公 共卫生与管理学 院院长马利军等 领导专家应邀出 席开班仪式，高 州市中医院党委 书记吴任鸿、院 长陈钦等党政领 导班子以及全体 中层干部参加活 动，开班仪式由 陈钦主持。 凝聚共识，锚定 发展新方向 临床药学研究基 地"、优化医院 管理体系等举 措，全面提升高 州市中医院的医 疗服务、科研能 力、专科建设及 人才培养水平， 为粤西地区中医 药资源升级注入 强劲动力。 高州市中医院党委书记吴任鸿致辞 开班仪式上，吴 任鸿代表医院党 政领导班子向莅 临现场的领导专 家表示热烈欢 迎。他指出，此 次培训作为广州 中医药大学"组 团式"帮扶框架 协议签订后的首 期活动，是提升 管理效能的关键 抓手。他强调 ...

Core Viewpoint - The establishment of the "National Medicine AI Avatar" product by Guoshengtang represents a significant milestone in the application of AI technology within traditional Chinese medicine, potentially reshaping the service model and competitive landscape of the industry [1][2]. Group 1: AI Product Launch and Impact - Guoshengtang has launched its first "National Medicine AI Avatar," which replicates the capabilities of renowned physician Li Hao, allowing for enhanced patient service and significantly increasing the supply of quality medical care [2][3]. - The AI Avatar product is seen as a breakthrough in addressing the challenges faced by the traditional Chinese medicine sector, such as the scarcity of top experts and long training cycles for new practitioners [6][7]. Group 2: Infrastructure and Resource Development - Since its establishment in 2010, Guoshengtang has developed a proprietary IT system, accumulating extensive medical data, including 17 million patient visits and over 8 million cases, which supports the training and optimization of AI models [4]. - The company has built a network of 8 national masters and hundreds of provincial-level renowned physicians, facilitating real-time feedback and continuous improvement of AI capabilities [4][9]. Group 3: Business Model and Growth Strategy - Guoshengtang aims to transition from a medical service provider to an AI medical platform, creating new revenue streams and growth models through the deployment of AI technologies [7][8]. - The AI Avatar allows the company to serve a larger patient base simultaneously, leading to exponential growth in potential customers and a significant expansion of market size [8]. Group 4: Long-term Value and Competitive Advantage - The integration of AI technology not only enhances service efficiency but also reduces marginal costs, potentially increasing profit margins and overall profitability [8]. - By cultivating young doctors through AI training, Guoshengtang is positioned to dominate talent supply in the industry, enhancing its competitive edge and industry influence [9].

固生堂 02273.HK 公司研究 | 首次报告 | | | ——固生堂首次覆盖报告 核心观点 盈利预测与投资建议 ⚫ 我们预测公司 2025-2027 年每股收益为 1.53、1.81 和 2.24 元。公司是国内领先中医 连锁服务龙头，AI 布局靠前，据可比公司 25 年平均估值，给予公司当年 26 倍市盈 率，对应目标价 43.37 港元（按 1：0.91517 汇率测算），首次给予"买入"评级。 风险提示 中药集采与供应链、合规经营、优质中医师资源不足、行业竞争加剧风险 公司主要财务信息 | | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入(百万元) | 2323.35 | 3022.38 | 3777.96 | 4574.38 | 5717.88 | | 同比增长 (%) | 43.01% | 30.09% | 25.00% | 21.08% | 25.00% | | 营业利润(百万元) | 229.36 | 319.07 | 387.06 | 468.15 | 590.16 ...